BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei L, Zhao T, Zhang J, Mao Q, Gong G, Sun Y, Chen Y, Wang M, Tan D, Gong Z, Li B, Niu J, Li S, Gong H, Zou L, Zhou W, Jia Z, Tang Y, Fei L, Hu Y, Shang X, Han J, Zhang B, Wu Y. Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial. Hepatology 2022;75:182-95. [PMID: 34396571 DOI: 10.1002/hep.32109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Zhao T, Wei L, Wu Y. Reply. Hepatology 2022. [PMID: 35202491 DOI: 10.1002/hep.32423] [Reference Citation Analysis]
2 Yardeni D, Ghany MG. Review article: hepatitis B-current and emerging therapies. Aliment Pharmacol Ther 2022;55:805-19. [PMID: 35224760 DOI: 10.1111/apt.16828] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sriwidodo, Umar AK, Wathoni N, Zothantluanga JH, Das S, Luckanagul JA. Liposome-Polymer Complex for Drug Delivery System and Vaccine Stabilization. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e08934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Song Y, Xing H, Zhou L, Zhang N, Yang M. LncRNA H19 modulated by miR-146b-3p/miR-1539-mediated allelic regulation in transarterial chemoembolization of hepatocellular carcinoma. Arch Toxicol 2021;95:3063-70. [PMID: 34251499 DOI: 10.1007/s00204-021-03119-8] [Reference Citation Analysis]
5 Jiménez-cabello L, Utrilla-trigo S, Barreiro-piñeiro N, Pose-boirazian T, Martínez-costas J, Marín-lópez A, Ortego J. Nanoparticle- and Microparticle-Based Vaccines against Orbiviruses of Veterinary Importance. Vaccines 2022;10:1124. [DOI: 10.3390/vaccines10071124] [Reference Citation Analysis]
6 Fan J, Fu JL, Wang FS. Boosting viral-specific immunotherapy for chronic hepatitis B treatment. Cell Mol Immunol 2021;18:2586-7. [PMID: 34782758 DOI: 10.1038/s41423-021-00788-4] [Reference Citation Analysis]
7 Patwa AK, Rungta S, Kumar V. Letter to the editor: Nanoparticle therapeutic vaccine for hepatitis B: An unfulfilled dream. Hepatology 2022. [PMID: 35226773 DOI: 10.1002/hep.32421] [Reference Citation Analysis]
8 Tian W, Zhou J, Chen M, Qiu L, Li Y, Zhang W, Guo R, Lei N, Chang L. Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity. Sci Rep 2022;12:11632. [PMID: 35804089 DOI: 10.1038/s41598-022-15866-4] [Reference Citation Analysis]